<--Back to project organisation page
Work package 2
Within the general objective of screening for drug candidates targeting
aberrant molecular signaling in protein phosphorylation pathways, WP2 is devoted
to screening and profiling of compound libraries as basis for rational drug
discovery.
| Groups in WP 2: |
||
| Université de Genève Laboratoire de chimie thérapeutique Section de pharmacie |
||
| Prof.
Leonardo Scapozza |
||
| The Hebrew
University of Jerusalem The Alexander Silberman Institute of Life Sciences Department of Biological Chemistry Unit of Cellular Signalling |
||
| Prof. Alexander Levitzki |
||
| University of Innsbruck Institute of Pharmacy Computer-Aided Molecular Design Group |
||
| Prof. Thierry Langer |
||
| C3Biotech | ||
| Dr. Paul Pechan |
||
| Inte:Ligand GmbH Software Development Unit |
||
| Dr. Gerhard Wolber |
||